Evidence map›Paper›PMID 34966926›Full record

ArticleGigaScience2021

Interpretable network propagation with application to expanding the repertoire of human proteins that interact with SARS-CoV-2.

Jeffrey N Law, Kyle Akers, Nure Tasnina, Catherine M Della Santina, Shay Deutsch, Meghana Kshirsagar, Judith Klein-Seetharaman, Mark Crovella, Padmavathy Rajagopalan, Simon Kasif and 1 more

Open access · goldAbstract read
In one paragraph

Article in GigaScience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Potential Drugs in COVID-19 Management.Current medicinal chemistry · 2024
    Review
  2. Article
  3. World journal of clinical cases · 2022
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Jeffrey N LawInterdisciplinary Ph.D. Program in Genetics, Bioinformatics, and Computational Biology, Virginia Tech, Blacksburg, VA 24061, USA.ORCID 0000-0003-2828-1273
Kyle AkersInterdisciplinary Ph.D. Program in Genetics, Bioinformatics, and Computational Biology, Virginia Tech, Blacksburg, VA 24061, USA.ORCID 0000-0001-5093-4619
Nure TasninaDepartment of Computer Science, Virginia Tech, Blacksburg, VA 24061, USA.
Catherine M Della SantinaDepartment of Biomedical Engineering, Boston University, Boston, MA 02215, USA.ORCID 0000-0002-6693-1022
Shay DeutschDepartment of Mathematics, University of California, Los Angeles, CA 90095, USA.ORCID 0000-0001-7623-6376
Meghana KshirsagarAI for Good Lab, Microsoft, Redmond, WA 98052, USA.ORCID 0000-0002-4673-614X
Judith Klein-SeetharamanDepartment of Chemistry, Colorado School of Mines, 1500 Illinois St, Golden, CO 80401, USA.ORCID 0000-0002-4892-6828
Mark CrovellaDepartment of Computer Science, Boston University, Boston, MA 02215, USA.ORCID 0000-0002-5005-7019
Padmavathy RajagopalanDepartment of Chemical Engineering, Virginia Tech, Blacksburg, VA 24061, USA.ORCID 0000-0001-9997-4953
Simon KasifDepartment of Biomedical Engineering, Boston University, Boston, MA 02215, USA.ORCID 0000-0003-3297-9914
T M MuraliDepartment of Computer Science, Virginia Tech, Blacksburg, VA 24061, USA.ORCID 0000-0003-3688-4672
Virginia Tech · USBoston University · USColorado School of Mines · USMicrosoft (United States) · USUniversity of California, Los Angeles · US

Funding

Boston UniversityNational Science Foundation DBI-1759858
6 · The paper itself

Abstract

backgroundNetwork propagation has been widely used for nearly 20 years to predict gene functions and phenotypes. Despite the popularity of this approach, little attention has been paid to the question of provenance tracing in this context, e.g., determining how much any experimental observation in the input contributes to the score of every prediction.

resultsWe design a network propagation framework with 2 novel components and apply it to predict human proteins that directly or indirectly interact with SARS-CoV-2 proteins. First, we trace the provenance of each prediction to its experimentally validated sources, which in our case are human proteins experimentally determined to interact with viral proteins. Second, we design a technique that helps to reduce the manual adjustment of parameters by users. We find that for every top-ranking prediction, the highest contribution to its score arises from a direct neighbor in a human protein-protein interaction network. We further analyze these results to develop functional insights on SARS-CoV-2 that expand on known biology such as the connection between endoplasmic reticulum stress, HSPA5, and anti-clotting agents.

conclusionsWe examine how our provenance-tracing method can be generalized to a broad class of network-based algorithms. We provide a useful resource for the SARS-CoV-2 community that implicates many previously undocumented proteins with putative functional relationships to viral infection. This resource includes potential drugs that can be opportunistically repositioned to target these proteins. We also discuss how our overall framework can be extended to other, newly emerging viruses.

Indexed as

COVID-19SARS-CoV-2AlgorithmsHumansProtein Interaction MapsProteinsProteinsCOVID-19interpretable machine learningnetwork propagationprovenance tracingSARS-CoV-2virus-host protein interaction networks

Identifiers

PMID34966926
PMCPMC8716363
OpenAlexW3215261967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.